ArticleFrontiers in microbiology2025
Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Biological control agents (BCAs) offer an environmentally friendly alternative to chemical pesticides for plant disease management. However, the efficacy of live microbial BCAs is often compromised by ecological constraints. Cell-free supernatants (CFSs), derived from BCA fermentation, contain most active biocontrol compounds responsible for disease suppression and can be directly applied without introducing living organisms into the environment. Our prior work demonstrated that CFS from Methods: Tomato seedlings were foliar-sprayed with CFS-Q or controls. Systemic resistance was assessed by challenging distal leaves with Results: Application of CFS-Q triggered immune responses in tomato seedlings, conferring enhanced local and systemic resistance against Discussion: CFS-Q operates via a dual mechanism: direct antagonism (established previously) and induced systemic resistance (ISR), evidenced by immune pathway activation. The priming effect ensures rapid defense mobil.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.